University of Vermont

College of Medicine

Department of Medicine


Hematology Oncology University of Vermont College of Medicine
Lake & Mountains & UVM

Education, Research, Clinical Care

The Hematology/Oncology Division faculty is committed to the three pillars of state-of-the-art patient care, research, and an outstanding training environment. We treat patients with all cancer types, and those with benign hematological disorders.


Providers, Residents & Fellows: find referral information and a clinical faculty & staff directory at Fletcher Allen Health Care.

Research & Education

The research mission of the Hematology/Oncology Division involves the exchange of knowledge from bench to bedside and back. Our research includes:

  • Translational Research
  • Epidemiology
  • Clinical Research
  • Public Health Research

We educate health care professionals at all levels of training, from medical and doctoral students to postdoctoral fellows, and members of the community.

Vermont Cancer Center

The Vermont Cancer Center is committed to innovative cancer research, life-saving prevention and treatment programs, public education and scientific collaboration, and serves to optimize cancer prevention, screening, diagnosis and care across Vermont and northern New York.

Drs. Zakai & Greenblatt
Neil Zakai, MD, MSc
Marc Greenblatt, MD

Neil Zakai, M.D., M.Sc., was named the 2013 Junior Researcher of the Year.

This award recognizes exemplary performance in representing the UVMMG in the advancement of medical research. Zakai, is an associate professor of medicine and pathology and joined the UVM/ Fletcher Allen faculty in 2007. He has an impressive list of research accomplishments. To read the complete article, click here. (1/16/2014 by Jenifer Nachbur)

Greenblatt Co-authors International Study that Provides Clearer Picture of Cancer Risk

Marc Greenblatt, MD, a University of Vermont researcher, has helped to develop a more accurate way of studying genetic changes to identify people at high risk for colon and other cancers. The findings are published in Nature Genetics. Greenblatt and his international collaborators focused on genetic variation in four genes that are responsible for Lynch Syndrome. Patients in Vermont and New York will have access to these new tools through the Vermont Cancer Center’s Familial Cancer Program at UVM/Fletcher Allen. To read the complete article, click here. (01-08-2014 By Sarah Lyn Cobleigh Keblin)



Last modified February 03 2014 04:13 PM